Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 3
1(33.3%)
3Total
N/A(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07240038Recruiting

Reduction of the Incidence of NAV in Neonatal Units (INBERNAV-Neo)

Role: collaborator

NCT03239808Not ApplicableActive Not Recruiting

Incremental Haemodialysis in Incident Patients

Role: collaborator

NCT06286007Recruiting

Prevalence and Impact of Pertussis and RSV on Asthma Severity and Control

Role: collaborator

NCT05513755Not ApplicableUnknown

Cardioneuroablation in Reflex Syncope (CARDIOSYRE Trial)

Role: collaborator

NCT04347278Unknown

Observational Study of Follow-up of Hospitalized Patients Diagnosed With COVID-19 to Evaluate the Effectiveness of the Drug Treatment Used to Treat This Disease. COVID-19 Registry

Role: collaborator

NCT01299922Phase 3Withdrawn

Clinical Trial Treatment in Lupus Nephritis

Role: collaborator

All 6 trials loaded